Exemestane
Steroidal aromatase inhibitor for hormone-positive breast cancer.
- Starts working
- Depends on the cancer and regimen
- Half-life
- About 24 hours
- In use since
- —
- Pregnancy
- Usually avoided
Overview
Exemestane is used after menopause, often after tamoxifen. It lowers oestrogen by irreversibly blocking aromatase, and can cause hot flushes and bone loss.
Conditions it's used for
How it works
Lowers oestrogen that fuels breast cancer.
Exemestane belongs to the Aromatase inhibitors. How Aromatase inhibitors work: block the enzyme that makes oestrogen in fat tissue — the main source after menopause.
Uses
- Hormone-receptor-positive breast cancer after menopause
Available as: tablet.
Typical dose
- Adults
- Dosed by your cancer team according to the treatment protocol.
- Good to know
- Doses depend on body size, blood counts and the regimen.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Hot flushes
- Joint pain
- Tiredness
- Sweating
- Insomnia
Serious — get medical help
Uncommon, but need prompt attention
- Bone thinning
- Liver enzyme rise
Warnings
- Take after food
- Bone density is checked
Who should avoid it
- Premenopausal women (unless ovarian suppression)
- Pregnancy
Interactions
- Rifampicin, St John's wort — lower levels
- Oestrogen-containing products — oppose effect
Other medicines in the atlas that need care with Exemestane, grouped by the reason:
Reduced effectModerateWith Carbamazepine, Efavirenz, Enzalutamide, Griseofulvin, Modafinil and 5 more
Enzyme induction lowers levels of this medicine, which may stop it working.
What's usually done: Monitor effect; dose changes or alternatives may be needed. The effect lasts weeks after stopping the inducer.
Raised drug levelsModerateWith Clarithromycin, Darunavir, Erythromycin, Itraconazole, Lopinavir-ritonavir and 2 more
Blocking CYP3A4 increases levels of this medicine, so side effects become more likely.
What's usually done: A dose reduction, alternative or extra monitoring may be needed.
Using it safely
- Alcohol
- Usually no problem in moderation. No specific interaction.
- Food and drink
- Take after a meal.
- If you miss a dose
- Take when remembered; skip if near the next dose.
- Stopping it
- Only on advice of your cancer team.
- Driving
- Tiredness or dizziness may affect driving.
- Tests and checks
- Bone density; Cholesterol
- If too much is taken
- Seek medical advice.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Usually avoided
Not for pregnancy.
Breastfeeding
Usually avoided
Avoid.
Special groups
- Kidney disease
- Dose may need adjusting; your team will advise.
- Liver disease
- Dose may need adjusting; your team will advise.
- Older adults
- Older adults may be more sensitive to side effects.
Brand names
- United States
- Aromasin
- United Kingdom
- Aromasin
- India
- Aromasin, Exemestane (generic)
- Australia
- Aromasin
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Exemestane?
Yes — Exemestane is prescription-only in most countries.
Can I take Exemestane during pregnancy?
Usually avoided. Not for pregnancy. Always check with a doctor or midwife.
How quickly does Exemestane work?
Depends on the cancer and regimen.
Related medicines
Anastrozole
Aromatase inhibitor for breast cancer treatment and prevention.
RxWHOAromatase inhibitorsLetrozole
Breast cancer hormone therapy after menopause; also a fertility drug.
RxWHOAromatase inhibitorsTamoxifen
Hormone therapy that has saved hundreds of thousands from breast cancer.
RxWHOSelective oestrogen receptor modulators
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — L02BG06
- WHO Model List of Essential Medicines
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.